Position in DYN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,080
New position
Shares Held
724
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#201
of 245 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMPASS FINANCIAL MANAGEMENT LLC holds $1,637,502 across 18 Biotechnology names. DYN ranks #9 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ATNM |
Actinium Pharmaceuticals, Inc.
|
600,230 | $588,225 | |
| 2 | OMER |
Omeros Corp
|
32,815 | $312,070 | |
| 3 | NWBO |
Northwest Biotherapeutics Inc
|
1,215,500 | $230,945 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
2,000 | $163,020 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
590 | $144,414 | |
| 6 | IMMX |
Immix Biopharma, Inc.
|
6,000 | $61,860 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102 | $50,666 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65 | $40,530 |
All Filings in DYN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,080 | 724 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||